Description
OPDIVO® 40mg Injection is used in the treatment of non-small cell lung cancer, kidney cancer, head and neck cancer, melanoma, Hodgkin’s disease, and liver cancer.
Additional information
| Brand | OPDIVO® 40 |
|---|---|
| Generic name | Nivolumab for Injection |
| Form | Parenteral |
| Strength | 40mg |
| Manufacturer | Bristol-Myers Squibb |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
Reviews
There are no reviews yet.